Sartorius Aktiengesellschaft Stock: price and insider trades · Germany

Headquartered in Göttingen, Germany, Sartorius Aktiengesellschaft belongs to the Healthcare & Pharma sector and traces its origins to 1870. Filings by its managers are published through BaFin. The last twelve months, up to 18 October 2026, brought 5 filings signed by 5 insiders.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €286k, made by 3 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 board members. One trade stands out by size: a purchase of €171k from Ebsworth GmbH, disclosed on 13 February 2026.

For context, the typical company on the same exchange (median of 287 companies) published 5 filings over the same period, against 5 filings here. The full history, which starts in 2025, counts 3 purchases against no sales.

The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 12 March 2026, 219 days ago. The median gap between a trade and its publication by BaFin is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade.

In the same sector, recent insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc also feature in our signals. These figures are compiled from regulatory filings published by BaFin. They describe what insiders did and are not a recommendation.